SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001387131-20-007240
Filing Date
2020-08-10
Accepted
2020-08-10 09:18:20
Documents
2
Period of Report
2020-08-10
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT tnxp-8k_081020.htm 8-K 24131
2 PRESS RELEASE ex99-01.htm EX-99.01 69856
  Complete submission text file 0001387131-20-007240.txt   95214
Mailing Address 509 MADISON AVE. - SUITE 1608 NEW YORK NY 10022
Business Address 509 MADISON AVE. - SUITE 1608 NEW YORK NY 10022 1-800-849-7894
Tonix Pharmaceuticals Holding Corp. (Filer) CIK: 0001430306 (see all company filings)

IRS No.: 261434750 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36019 | Film No.: 201087448
SIC: 2834 Pharmaceutical Preparations